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A real-time PCR assay was developed for rapid detection of eubacterial 16S ribosomal DNA in platelet
concentrates. The sensitivity of this assay can be hampered by contaminating DNA in the PCR reagents.
Digestion of the PCR reagents with Sau3AI prior to PCR amplification was effective in eliminating this
contaminating DNA without affecting the sensitivity of the assay.
Bacterial contamination of blood products is a major cause
of transfusion-related morbidity and mortality. Due to their
storage at 20 to 24°C, platelets are responsible for most of the
cases of blood component-associated sepsis (1, 6, 11). Re-
cently, Nadkarni et al. (12) have reported the use of universal
primers and probes to estimate the total bacterial load in
clinical samples. To detect bacterial contamination in platelet
concentrates (PCs), the DNA must be extracted as efficiently
as possible and the PCR mixture must not be contaminated by
DNA present in the PCR reagents. Poor efficiency of DNA
extraction may restrict the sensitivity of the assay, while DNA
that is contaminating PCR reagents can serve as a template in
PCRs, producing false-positive results. Attempts to reduce the
amount of contaminating DNA from, e.g., Taq polymerases (3,
4, 5, 7) in real-time PCR have been described previously (9, 10,
13, 15). None of these methods, however, proved very effective on
low copy numbers of bacterial ribosomal DNA in the PCR
reagents. In addition, these strategies affect the sensitivity of the
real-time PCR. Here, a rapid and sensitive PCR assay based on
TaqMan technology to detect bacterial contamination in PCs is
described.
Two different isolation methods were used to prepare tem-
plate DNA from PCs: a fully automated method with the
MagNA Pure LC instrument (Total Nucleic Acid isolation kit,
Roche Diagnostics) (8) and a manual extraction procedure
with the NucliSens extraction kit (bioMe´rieux) (2, 14). Two
strategies to reduce contaminating DNA in real-time PCR
amplification were evaluated and found to be suited to meet
the requirements of the PCR system to detect bacteria in PCs
without affecting the high sensitivity of the assay.
To determine the detection limit of the assay, 1 ml of PCs
was spiked with 100 l of serial dilutions of Escherichia coli.
The number of bacteria added to the PCs ranged from 10 to
20,000 CFU/ml. DNA was subsequently extracted from these
spiked PCs using both the MagNA Pure LC instrument and the
NucliSens extraction manual method.
In the MagNA Pure method, DNA was extracted from a 200-
l aliquot of spiked material and eluted in a final volume of 50
l. In the NucliSens method, DNA was purified from a 2,000-
l aliquot of spiked PCs and eluted in a final volume of 50 l.
In addition, DNA was extracted from serial dilutions of a pure
culture of E. coli by the same MagNA Pure extraction procedure.
A 466-bp fragment of the bacterial 16S ribosomal DNA was
amplified using the forward primer 5-TCCTACGGGAGGC
AGCAGT-3, the reverse primer 5-GGACTACCAGGGTA
TCTAATCCTGTT-3, and the probe (6-FAM)-5-CGTATT
ACCGCGGCTGCTGGCAC-3-(TAMRA) (12).
The PCRs were performed in a total volume of 25 l using the
TaqMan Universal PCR Master Mix on the ABI 7700 sequence
detection system (Applied Biosystems). The reactions comprised
900 nM (each) forward and reverse primers, 200 nM probe,
and 5 l of template DNA. Negative controls (unspiked PCs)
were included throughout the procedure. No-template controls
(NTC) with water instead of template DNA were incorporated in
each run under the following conditions: 50°C for 2 min, 95°C
for 10 min, and 40 cycles of 95°C for 15 min and 60°C for 1 min.
The result of each PCR is indicated by a threshold cycle (CT)
value. The detection limit of the assay was 1 CFU equivalent/
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TABLE 1. Detection limit of real-time PCR assay performed with
DNA isolated from PCs (spiked with E. coli) using either
MagNA Pure or NucliSens extraction procedure
No. of PCs spiked with E. coli
(CFU equivalent/PCR)
DNA extraction
method CT
a
8  101 NucliSens 27.84  0.43
8  100 NucliSens 31.58  0.13
4  100 NucliSens 32.80  0.21
2  100 NucliSens 33.40  0.26
1  100 NucliSens 34.73  0.70
2  102 MagNa Pure 31.11  0.42
4  101 MagNA Pure 33.42  0.10
4  100 MagNA Pure 34.83  0.83
1  100 MagNA Pure 35.42  0.45
a Mean  standard deviation of three independent experiments.
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PCR (Table 1). This corresponds to 100 CFU equivalents/ml of
spiked PCs by the MagNA Pure method and to 10 CFU equiv-
alents/ml with the NucliSens extraction kit. This difference is
due to the starting volumes of the clinical samples used to
extract DNA.
The initial PCR assays showed a high background, as can be
deduced from the threshold value of the NTC (Table 2); this
was probably due to the presence of traces of bacterial DNA in
the enzymes used in the PCR. Three pretreatment procedures
were used on the PCR mixtures for the reduction of this source
of contamination: digestion with Sau3AI, ultrafiltration, and
DNase I.
Digestion with Sau3AI. Sau3AI recognizes GATC sequences
and is active in the PCR mixture (to digest 1 g of substrate
DNA in 16 h, a minimum of 0.50 U is needed). Prior to the
addition of template DNA, the PCR mixture was subjected to
digestion with the enzyme Sau3AI (1 U/PCR; New England
Biolabs). After incubation at 37°C for 30 min, the solution was
heat inactivated at 65°C for 20 min. PCRs were subsequently
performed as described above.
Ultrafiltration. Before the addition of template DNA, the
PCR mixture was filtered with an Amicon Microcon YM-100
centrifugal filter device (Millipore Corp.) as described by Yang
et al. (16). The PCR mixture was passed through the YM-100
filter unit at 100  g for 30 min.
DNase I treatment. DNase I (Amersham Pharmacia Bio-
tech) (1 U of activity of this nonspecific endonuclease causes
an increase in absorbance at 260 nm of 0.001/min/ml at 25°C
with DNA as a substrate) was added to the PCR mixture (0.2
U/PCR) without template DNA. The solution was incubated at
37°C for 10 min, followed by heat denaturation at 65°C for 15
min. After this treatment, template DNA was added and the
PCR was carried out.
The PCR performed on DNA obtained by either of the two
isolation methods described in this paper was very sensitive,
and as little as 1 CFU equivalent/reaction mixture could be
detected. DNA extraction by the NucliSens method, however,
requires a 10-fold larger volume of PCs than the MagNA Pure
method: 2,000 instead of 200 l. The extraction methods also
differ in operating time: with the MagNA Pure LC instrument,
results can be obtained within 4 h, while the NucliSens extrac-
tion kit requires 6 h.
Digestion of the PCR mixture with Sau3AI reduced the
amplification signal of the NTC by two PCR cycles (Table 2).
Amplification of the reaction mixtures containing template
DNA increased accordingly, with one or two PCR cycles, while
1 CFU equivalent/reaction was still detectable.
Filtration of the PCR mixture through a YM-100 filtration
unit resulted in an increase of the CT of the NTC to 40, which
indicated that contaminating DNA was eliminated. Filtration
of the PCR mixture before the addition of template DNA,
however, also reduced the sensitivity of the assay (Table 2).
Pretreatment of the PCR mixtures with DNase I led to an
unexpected decrease in the CT values of all PCRs, including
that of the NTC (Table 2).
Similar results were found when PCR assays were per-
formed with DNA isolated from spiked PCs (Table 3).
The problem of contamination present in the reagents used
in the PCR was solved by two of the three tested methods:
digestion with Sau3AI or removal of DNA by ultrafiltration.
Removal of any trace of DNA from the reaction mixtures
allows the achievement of maximal sensitivity of the real-time
PCR assay.
Digestion with Sau3AI proved to be effective in reducing
contamination of the PCR mixture, as shown by the increase of
the mean CT of the NTC. In the case of pretreatment with
Sau3AI, the detection limit remained 1 CFU equivalent/PCR.
Following the prefiltration procedure, a mean CT of 40 was
generated for the NTC. However, the sensitivity of the assay
performed with DNA isolated from spiked PCs was reduced to
30 CFU equivalents/PCR. Thus, Sau3AI seems to be effective,
especially when detection of only a few molecules of a target
TABLE 2. Detection limit of assay with DNA extracted from a pure culture of E. coli and serially diluteda
Sample type
CT for template E. coli DNA in the following units (CFU equivalents/PCR)b:
NTC 7.5  105a 7.5  104 7.5  103 7.5  102 7.5  101 7.5  100 100
Untreated 34.56  0.08 21.39  0.40 25.73  0.24 29.9  0.21 33.37  0.7 34.8  0.27 35.07  1.04 34.58  0.34
Sau3A1 37.46  0.09 22.62  1.32 25.83  0.01 30.2  0.06 33.77  1.69 35.97  1.44 36.61  2.39 36.03  2.80
Filter 40.00  0 22.15  0.03 26.11  0.81 30.51  0.03 34.59  0.11 37.6  0.08 40.00  0 40.00  0
DNase I 24.53  0.08 26.20  0.78 21.95  1.03 23.47  0.20 23.89  0.55 24.84  0.02 24.25  0.19 25.04  0.06
a DNA extraction was done with the MagNA Pure LC instrument. The results of different pretreatments (digestion with Sau3AI, filtration, and treatment with DNase
I) are also presented.
b Mean  standard deviation of three independent runs.
TABLE 3. Detection limit of assay with DNA extracted from PCs spiked with E. coli DNA without treatment and
pretreated by Sau3AI, ultrafiltration, and DNase I
Sample type
CT for template DNA isolated from PCs spiked with E. coli in the following amts (CFU equivalent/PCR)a:
NTC 3  103 3  102 3  101 3  100
Untreated 34.56  0.08 29.59  1.26 33.40  0.31 34.93  0.66 34.72  0.30
Sau3A1 37.46  0.09 29.82  1.68 33.8  0.36 35.84  0.43 36.01  0.74
Filter 40.00  0 30.55  0.05 34.01  1.11 39.37  0.40 40.00  0
DNase I 24.53  0.08 23.63  0.72 23.00  0.36 23.15  1.08 25.40  0.43
a Mean  standard deviation of three independent runs.
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DNA sequence is required. When a detection limit of 10
CFU equivalents/reaction is not needed, prefiltration of the
PCR mixture seems to be more appropriate.
Both methods can be simply integrated into the PCR pro-
cedure to overcome the problem of contaminating DNA. Pre-
treatment with Sau3AI extends the assay by 50 min, whereas
the prefiltration step prolongs the PCR by 30 min. Pretreat-
ment with DNase I resulted in an unexplainable decrease in
the CT values of all PCRs. This nonspecific endonuclease
cleaves both DNA strands. During single-strand digestions,
DNase I causes gaps and nicks that can be repaired by DNA
polymerase. Possibly, this process makes the target sequence
more accessible and the amplification of contaminating DNA
more efficient. As a result a decrease in the CT values of all
PCRs occurred. Since the results of this pretreatment were not
consistent, the use of this enzyme to reduce contaminating
DNA is not favorable.
In summary, real-time PCR assay in combination with the
automated MagNA Pure DNA extraction method meets the
requirements for pretransfusion screening of PCs: the assay
takes only 4 h to be completed and has the capability to detect
very small numbers of bacteria.
When contaminating DNA is a limitation, digestion of the
PCR mixture with Sau3AI can be used to remove contaminat-
ing DNA without affecting the sensitivity of the assay.
Before this assay can be implemented as a tool to screen
PCs for bacterial contamination, further validation studies are
needed.
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